About ASMS

About Member-at-Large for Membership

The Member-at-Large (MAL) for Membership serves a two-year term. Duties and responsibilities include:

  1. Chairs the Membership Committee and serves as liaison to the Board;
  2. Coordinates activities and projects that promote inclusion and participation of ASMS members from diverse cultural, gender, social and scientific backgrounds;
  3. Recommends initiatives to support career development;

Return to Board of Directors Election page to learn about other roles and their nominees.

Candidates for Member-at-Large Membership

Schweppe

Devin K. Schweppe

University of Washington

Candidate Statement
As a longtime member of ASMS, I have greatly benefited from the society as a trainee, mentee, and now also as a PI. I want to serve as the Member-at-Large for Membership to ensure ASMS continues to foster a welcoming environment for a growing and diverse community, build opportunities for career development and mentorship, and give back to the community that has supported me since the beginning of my research career.

Devin K. Schweppe, B.A. in Chemistry (Williams College); Ph.D. in Genetics (Giesel School of Medicine [Dartmouth] with Dr. Scott A. Gerber); Postdoctoral Fellow (University of Washington with Dr. James Bruce); Postdoctoral Fellow (Harvard Medical School with Dr. Steven Gygi).  Dr. Schweppe is currently an Assistant Professor in the Department of Genome Sciences at the University of Washington in Seattle, WA.

Dr. Schweppe’s research interests focus on the implementation of millisecond informatics to enable intelligent data acquisition strategies. His research group applies these technologies to quantify proteins as a readout for diverse cell states with broad interests spanning microbial protein interactions, small-molecule binding events, pre-clinical proteomics, and profiling primary tissue samples. Dr. Schweppe’s research efforts currently build on the application of sample multiplexing and real-time search to achieve high efficiency instrument acquisition for both discovery and targeted proteomics platforms. Along with the methods and technology development focus, Dr. Schweppe built, or helped build, applications and resources to disseminate large-scale proteomics datasets to the research community, these efforts include work the crosslinking mass spectrometry repository XLinkDB and the BioPlex Explorer human interactome interactive viewer. 

As an ASMS member since 2008, Dr. Schweppe has been a long-time contributor/presenter, an organizer for special interest discussions and workshops, and a session chair at the Annual Conference. Currently, Dr. Schweppe is a member of the ASMS Digital Communications Committee and the Coalition for Black Mass Spectrometrists. He has also participated as an early career reviewer for the NIH grant review, serves on the Board of Directors for US HUPO, and has been a member of US HUPO, HUPO, AAAS, and ASBMB.

Ulmer

Candice Z. Ulmer

Centers for Disease Control and Prevention (CDC)

Candidate Statement
As an advocate for STEM outreach and diversity/equity/inclusion (DEI) efforts, the current chair of the ASMS Diversity and Inclusion Committee, and the co-founder of the Coalition for Black Mass Spectrometrists, I strongly support the broadened goals for the ASMS BoD Member at Large for Membership position. In these roles and my other external committee positions within the diversity scope, I have facilitated listening sessions for the membership and ensured the integration of environmental justice into all aspects of environmental public health work (i.e., public health assessments, laboratory work, tool development, research, national surveys, etc.). If elected I will strive to [1] ensure that our mentorship/REU programs and current/future initiatives reflect the needs/make-up of the membership, [2] sculpt these data-driven initiatives and programs to increase member retention/participation, and [3] guarantee diversity, equity, and inclusivity within the society.

Candice Z. Ulmer, Ph.D., B.S. in Chemistry (College of Charleston, Charleston, SC); B.S. in Biochemistry (College of Charleston, Charleston, SC); Ph.D. in Chemistry (University of Florida, Gainesville, FL – direction of Drs. Richard A. Yost and Timothy Garrett); National Research Council Postdoctoral Fellowship (National Institute of Standards and Technology – direction of Dr. John Bowden). Dr. Ulmer is currently a Senior Service Fellow, Clinical Research Chemist, and Project Lead in the Clinical Chemistry Branch of the Centers for Disease Control and Prevention (CDC) in Atlanta, GA.

Dr. Ulmer’s responsibilities include the accurate measurement of chronic disease biomarkers through the development of mass spectrometric reference measurement procedures for small molecules and proteins, the assessment of routine clinical analytical methods in patient care, and the integration/translation of analytical approaches to predict health risks and disease progression. She works to plan and execute standardization programs to ensure that clinical measurements, no matter when and where they are received, are always accurate and reproducible. Her talents and contributions as an early-career mass spectrometrist with over 30 peer-reviewed articles, book chapters, and application notes, were recognized in the June 2018 issue of the JASMS “Faces of Mass Spectrometry”. 

Apart from her numerous oral/poster presentations since the beginning of her ASMS membership in 2013, Dr. Ulmer has organized and chaired sessions on the application of mass spectrometry at several ASMS Conferences. She currently serves as the co-chair of the ASMS clinical chemistry interest group (2018 – present) and chair of the ASMS diversity & inclusion committee (2021 – present). Dr. Ulmer has previously served on the ASMS publication committee (2018 – 2020) and ASMS diversity & inclusion committee (2020 – present). Apart from her roles within ASMS, Dr. Ulmer assumes appointed/elected memberships in other scientific organizations that include the International Metabolomics Society (MetSoc), the Metabolomics Quality Assurance and Quality Control Consortium (mQACC), Metabolomics of North America (MANA), the International Lipidomics Society (ILS), and the American Chemical Society (ACS). In addition, Dr. Ulmer was nominated by the American Association of Clinical Chemistry (AACC) to serve on the newly-formed International Federation of Clinical Chemistry and Laboratory Medicine (IFCC) Committee on Bone Metabolism.